1. Home
  2. LARK vs LXRX Comparison

LARK vs LXRX Comparison

Compare LARK & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LARK
  • LXRX
  • Stock Information
  • Founded
  • LARK 1885
  • LXRX 1995
  • Country
  • LARK United States
  • LXRX United States
  • Employees
  • LARK N/A
  • LXRX N/A
  • Industry
  • LARK Major Banks
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LARK Finance
  • LXRX Health Care
  • Exchange
  • LARK Nasdaq
  • LXRX Nasdaq
  • Market Cap
  • LARK 167.5M
  • LXRX 124.4M
  • IPO Year
  • LARK N/A
  • LXRX 2000
  • Fundamental
  • Price
  • LARK $29.68
  • LXRX $0.67
  • Analyst Decision
  • LARK
  • LXRX Buy
  • Analyst Count
  • LARK 0
  • LXRX 4
  • Target Price
  • LARK N/A
  • LXRX $3.67
  • AVG Volume (30 Days)
  • LARK 31.0K
  • LXRX 5.9M
  • Earning Date
  • LARK 04-30-2025
  • LXRX 05-13-2025
  • Dividend Yield
  • LARK 2.96%
  • LXRX N/A
  • EPS Growth
  • LARK 27.69
  • LXRX N/A
  • EPS
  • LARK 2.59
  • LXRX N/A
  • Revenue
  • LARK $60,798,000.00
  • LXRX $31,081,000.00
  • Revenue This Year
  • LARK N/A
  • LXRX N/A
  • Revenue Next Year
  • LARK N/A
  • LXRX $84.78
  • P/E Ratio
  • LARK $11.20
  • LXRX N/A
  • Revenue Growth
  • LARK 9.30
  • LXRX 2481.48
  • 52 Week Low
  • LARK $17.53
  • LXRX $0.28
  • 52 Week High
  • LARK $31.04
  • LXRX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • LARK 55.52
  • LXRX 59.29
  • Support Level
  • LARK $28.40
  • LXRX $0.63
  • Resistance Level
  • LARK $31.00
  • LXRX $0.71
  • Average True Range (ATR)
  • LARK 1.10
  • LXRX 0.07
  • MACD
  • LARK -0.14
  • LXRX -0.00
  • Stochastic Oscillator
  • LARK 41.75
  • LXRX 51.27

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Share on Social Networks: